Wichterman Troy's Form 4/A amendment
AmendedBiolife Solutions Inc (BLFS) · filed Feb 17, 2022
- Accession no.
- 0001437749-22-003761
- Filed
- Feb 17, 2022
- Trade date
- Jan 7, 2022
- Filing delay
- 41 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jan 11, 2022
This filing lists 1 non-derivative transaction. Open-market sales total $1.45K. It was filed 41 days after the trade.
This amendment replaces 0001437749-22-000744 (filed Jan 11, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wichterman TroyCIK 0001892616 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2022 | Common Stock | SSaleDisposed | −47 | $30.75 | −$1,445.25 | 22,075 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
- F2
On January 11, 2022, the reporting person filed a Form 4 which inadvertently reported in Column 4 of Table I that the sale to cover transaction was an acquisition of securities rather than a disposition of securities. In fact, as reported in this amendment, the reporting person disposed of those shares.